OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of luteolin in overcoming Parkinson's disease
Yasir Hasan Siddique
BioFactors (2021) Vol. 47, Iss. 2, pp. 198-206
Closed Access | Times Cited: 25

Showing 25 citing articles:

Luteolin: A promising natural agent in management of pain in chronic conditions
Foteini Ntalouka, Athina Tsirivakou
Frontiers in Pain Research (2023) Vol. 4
Open Access | Times Cited: 47

Luteolin for neurodegenerative diseases: a review
Dunuvilla Kavindi Jayawickreme, Cletus Ekwosi, Apurva Anand, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 644-664
Open Access | Times Cited: 14

Flavonoids as Potential Therapeutics Against Neurodegenerative Disorders: Unlocking the Prospects
Md. Faysal, Zerrouki Dehbia, Mehrukh Zehravi, et al.
Neurochemical Research (2024) Vol. 49, Iss. 8, pp. 1926-1944
Closed Access | Times Cited: 8

Exploring the mechanism of luteolin by regulating microglia polarization based on network pharmacology and in vitro experiments
Tianyue Wang, Yuanjun Yin, Xinyu Jiang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 20

Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease
Ahsas Goyal, Kunal Solanki, Aanchal Verma
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 19

Alzheimer, Parkinson, dementia, and phytochemicals: insight review
Başak CAN, Nevin Şanlıer
Critical Reviews in Food Science and Nutrition (2024), pp. 1-23
Closed Access | Times Cited: 6

Luteolin: a natural product with multiple mechanisms for atherosclerosis
Chanjun Wan, Qingzhi Liang, Yirong Ma, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Role of Natural Compounds Modulating Heme Catabolic Pathway in Gut, Liver, Cardiovascular, and Brain Diseases
Sri Jayanti, Libor Vı́tek, Camilla Dalla Verde, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 63-63
Open Access | Times Cited: 3

Role of Plant Phytochemicals: Resveratrol, Curcumin, Luteolin and Quercetin Indemyelination, Neurodegeneration, and Epilepsy
M Grabarczyk, Weronika Justyńska, Joanna Czpakowska, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1364-1364
Open Access | Times Cited: 3

Luteolin protects DYT-PRKRA cells from apoptosis by suppressing PKR activation
Kenneth Frederick, Rekha C. Patel
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8

The flavonoid luteolin reduces mutant huntingtin aggregation and cytotoxicity in huntingtin-mutated neuroblastoma cells
Azza Ramadan, Abuelnor Mohammed, Asim Ahmed Elnour, et al.
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 12, pp. 101871-101871
Open Access | Times Cited: 7

Luteolin Exhibits Anxiolytic and Antidepressant Potential in Parkinson’s Disease Rat: Antioxidant and Anti-Inflammatory Effects
Ruifang She, Zhaoting Zhang, Miaomiao Han, et al.
Rejuvenation Research (2024)
Closed Access | Times Cited: 2

Luteolin: The wonder flavonoid
Theoharis C. Theoharides
BioFactors (2021) Vol. 47, Iss. 2, pp. 139-140
Closed Access | Times Cited: 11

In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo–keto reductases
Gzona Bajraktari‐Sylejmani, Julia Sophie Oster, Jürgen Burhenne, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 807-820
Open Access | Times Cited: 1

Attenuation of cannabis withdrawal symptoms by Prosopis farcta extract, its luteolin and melatonin in mice: Involvement of brain‐derived neurotrophic factor and dopamine
Javad Ghasemian‐Yadegari, Ahmad Adineh, Hamidreza Mohammadi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Closed Access | Times Cited: 1

INVESTIGATING MULTITARGET POTENTIAL OF MUCUNA PRURIENS AGAINST PARKINSON'S DISEASE: INSIGHTS FROM MOLECULAR DOCKING, MMGBSA, PHARMACOPHORE MODELLING, MD SIMULATIONS AND ADMET ANALYSIS
Zakiya Fathima C, JAINEY P. JAMES, Mahendra Gowdru Srinivasa, et al.
International Journal of Applied Pharmaceutics (2024), pp. 176-193
Open Access | Times Cited: 1

Unlocking the neuroprotective potential of Ziziphora clinopodioides flavonoids in combating neurodegenerative diseases and other brain injuries
Lili Gu, Can Wang, Jiayi Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117744-117744
Closed Access | Times Cited: 1

Garcinia morella extract confers dopaminergic neuroprotection by mitigating mitochondrial dysfunctions and inflammation in mouse model of Parkinson’s disease
Ankumoni Dutta, Banashree Chetia Phukan, Rubina Roy, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 6, pp. 1887-1900
Closed Access | Times Cited: 6

Integrative multilevel exploration of the mechanism by which Er-Zhi-Wan alleviates the Parkinson's disease (PD)-like phenotype in the MPTP-induced PD mouse model
Botao Pan, Bo Niu, Yanjun He, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115021-115021
Open Access | Times Cited: 2

The Application of Ficus Species in the Treatment of Neurological Disorders
Alveera Alam, Papiya Mitra Mazumder
Pharmacognosy Magazine (2024)
Open Access

Luteolin improves mitochondrial dynamics and function in ulcerative colitis via the miR-195-5p/Notch signalling pathway
Min Liu, Yuge Wang, Zhao Liu, et al.
Journal of Functional Foods (2024) Vol. 124, pp. 106644-106644
Open Access

Waiting for PARIS—A Biological Target in Search of a Drug
Richard Wyse, Simon Stott, Leah Mursaleen, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 95-103
Open Access | Times Cited: 2

Exploring the mechanism of wendan decoction in the treatment of ischemic stroke using bioinformatics and network pharmacology
Ning Zhang, Qian Zhang, Ruisu Zhang, et al.
Medicine in Novel Technology and Devices (2022) Vol. 16, pp. 100172-100172
Closed Access

Page 1

Scroll to top